{"result": "(\"entity\"<|>BARIATRIC SURGERY<|>EVENT<|>Bariatric surgery is a surgical procedure aimed at weight loss and is associated with various health outcomes, including cardiovascular disease and mortality rates in patients with obesity.)\n##\n(\"entity\"<|>KWOK CS<|>PERSON<|>Kwok CS is an author of a study published in the International Journal of Cardiology regarding the impact of bariatric surgery on cardiovascular disease and mortality.)\n##\n(\"entity\"<|>SWEDEN<|>GEO<|>Sweden is the country where a nationwide study on cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery was conducted.)\n##\n(\"entity\"<|>LANCET DIABETES ENDOCRINOLOGY<|>ORGANIZATION<|>The Lancet Diabetes & Endocrinology is a medical journal that published a study on cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery.)\n##\n(\"entity\"<|>JAMA<|>ORGANIZATION<|>JAMA is a medical journal that published studies related to bariatric surgery and its impact on health outcomes.)\n##\n(\"entity\"<|>OBESITY<|>EVENT<|>Obesity is a medical condition that bariatric surgery aims to treat, often leading to various health complications.)\n##\n(\"entity\"<|>GALLSTONES<|>EVENT<|>Gallstones are a potential complication following bariatric surgery, often requiring consideration for treatment or prevention strategies.)\n##\n(\"relationship\"<|>KWOK CS<|>BARIATRIC SURGERY<|>Kwok CS authored a study that discusses the effects of bariatric surgery on cardiovascular disease and mortality<|>8)\n##\n(\"relationship\"<|>SWEDEN<|>BARIATRIC SURGERY<|>The study on cardiovascular disease and mortality after bariatric surgery was conducted in Sweden<|>7)\n##\n(\"relationship\"<|>LANCET DIABETES ENDOCRINOLOGY<|>BARIATRIC SURGERY<|>The Lancet Diabetes & Endocrinology published a study on the effects of bariatric surgery on health outcomes<|>6)\n##\n(\"relationship\"<|>JAMA<|>BARIATRIC SURGERY<|>JAMA published research related to the impact of bariatric surgery on various health outcomes<|>6)\n##\n(\"relationship\"<|>BARIATRIC SURGERY<|>OBESITY<|>Bariatric surgery is a treatment method for obesity<|>9)\n##\n(\"relationship\"<|>BARIATRIC SURGERY<|>GALLSTONES<|>Bariatric surgery can lead to the formation of gallstones, necessitating preventive measures<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: mortalidad en sujetos con cirugía bariátrica a largo plazo.\nBasado en Kwok CS et al. Int J Cardiol. 2014;173(1):20-8.\n\nReferencias:\n- Eliasson B, Liakopoulos V, Franzén S, Näslund I, Svensson AM, Ottosson J, et al. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. Lancet Diabetes Endocrinol. 2015;3(11):847-54.\n- Fisher DP, Johnson E, Haneuse S, Arterburn D, Coleman KJ, O'Connor PJ, et al. Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity. JAMA. 2018;320(15):1570-82.\n- Kwok CS, Pradhan A, Khan MA, Anderson SG, Keavney BD, Myint PK, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173(1):20-8.\n- Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56-65.\n\n## Respecto al bypass gástrico como técnica quirúrgica para el tratamiento de la obesidad, señale la respuesta falsa:\n\nA. El bypass gástrico distal añade un componente mayor malabsortivo que el bypass gástrico proximal.\nB. Se debe realizar colecistectomía profiláctica a todos los pacientes en el mismo acto quirúrgico.\nC. Las principales causas de mortalidad perioperatoria son la tromboembolia pulmonar y la dehiscencia de sutura.\nD. Pueden ser causa de ganancia de peso la dilatación del reservorio gástrico y de la anastomosis gastroduodenal.\n---\n# OBESIDAD, LÍPIDOS Y TRASTORNOS ELECTROLÍTICOS\n\n## COMENTARIO\n\nTradicionalmente, se realizaba colecistectomía profiláctica en todas las derivaciones biliopancreáticas porque la incidencia de colelitiasis tras la pérdida de peso era elevada. También en el caso de colelitiasis se solía asociar una colecistectomía en cualquier tipo de cirugía.\n\nDado que la colecistectomía supone un incremento importante del tiempo quirúrgico (unos 90 min extra) y la posibilidad de complicaciones asociadas, sigue siendo un tema de debate sin un consenso definido. En general, se recomienda realizar colecistectomía únicamente en el paciente sintomático, pues la posibilidad de presentar cólicos biliares y/o colecistitis tras la pérdida de peso es similar en el paciente con normopeso.\n\nSe ha recomendado de manera general la posibilidad de tratamiento con ácido ursodesoxicólico a los pacientes intervenidos de cirugía bariátrica durante un periodo de 6 meses (cuando la pérdida de peso es más acusada) para evitar la aparición de cálculos biliares, y aunque parece efectivo, la tolerancia y la adherencia en vida real es regular.\n\n### Referencias:\n\n- Magouliotis DE, Tasiopoulou VS, Svokos AA, Svokos KA, Chatedaki C, Sioka E, et al. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis. Obes Surg. 2017;27(11):3021-30.\n- Morais M, Faria G, Preto J, Costa-Maia J. Gallstones and Bariatric Surgery: To Treat or Not to Treat? World J Surg. 2016;40(12):2904-10.\n- Warschkow R, Tarantino I, Ukegjini K, Beutner U, Güller U, Schmied BM, et al. Concomitant Cholecystectomy During Laparoscopic Roux-en-Y Gastric Bypass in Obese Patients Is Not Justified: A Meta-Analysis. Obes Surg. 2013;23(3):397-407.\n\n## Le comentamos al paciente la necesidad de tomar suplementos vitamínicos posteriores al procedimiento quirúrgico. En este caso del bypass hay que tener especial atención con:\n\nA. La deficiencia de tiamina relacionada con los vómitos, relativamente frecuentes en los primeros meses de este tipo de cirugía.\nB. La deficiencia de vitamina A y F por maldigestión y malabsorción, después del primer año de la cirugía.\nC. La deficiencia de vitamina B12, debido a la exclusión del estómago.\nD. La deficiencia de zinc, muy frecuente tras los dos primeros años de la cirugía, debido a la exclusión del duodeno.\n\n## COMENTARIO\n\nLa deficiencia de vitamina B12 es frecuente en los pacientes intervenidos de bypass. La razón fundamental es que la mayor\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}